Loading clinical trials...
Loading clinical trials...
Abnormal uterine bleeding is the most common problems to discontinue Depo-medroxyprogesterone acetate (DMPA) in Thailand. This clinical trial use to provide drug to stop abnormal uterine bleeding from...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Department of Medical Services Ministry of Public Health of Thailand
NCT06184750 · Breast Atypical Ductal Hyperplasia, Breast Atypical Lobular Hyperplasia, and more
NCT07222215 · Estrogen-receptor-positive Breast Cancer, Metastatic Breast Cancer, and more
NCT07628660 · Female Sexual Dysfunction, Endometrial Sampling, and more
NCT06525766 · Anatomic Stage IV Breast Cancer AJCC v8, Estrogen-receptor-positive Breast Cancer, and more
NCT05846789 · Metastatic Breast Cancer, Triple Negative Breast Cancer, and more
Krittiporn Mahachiraphat
Bangkok, Ratchathewi
Krittiporn Mahachiraphat, M.D.
Phaya Thai, Ratchathewi
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions